Pettinga Financial Advisors, LLC Abbott Laboratories Transaction History

Pettinga Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $255,321 - $312,626	-2,210 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$116.66 - $129.06 $11,666 - $12,906	-100 Reduced 4.33%	2,210 $261,000
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $458 - $556	-5 Reduced 0.22%	2,310 $251,000
Q2 2020 Jul 22, 2020	BUY	$76.57 - $98.0 $177,259 - $226,870	2,315 New	2,315 $212,000
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $145,239 - $212,380	-2,312 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$78.51 - $87.4 $181,515 - $202,068	2,312 New	2,312 $201,000

3,204

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $216B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Pettinga Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Pettinga Financial Advisors, LLC with notifications on news.